Evidence map›Paper›PMID 42853426›Full record

ArticleActa neuropathologica2026

Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy ("dying back"): a clinical-neuropathological study.

Jianguo Liu, Kailee Ong, Alex Meng, Gorazd B Stokin, Jeffrey A Loeb, John Ravits, Fei Song

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jianguo LiuDepartment of Neurology and Rehabilitation, The University of Illinois at Chicago, NPI North Bldg., Room 174N, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA.
Kailee Ong *ALS and Neuromuscular Translational Research University of California, San Diego, CA, 92093, USA.
Alex Meng *ALS and Neuromuscular Translational Research University of California, San Diego, CA, 92093, USA.
Gorazd B StokinInstitute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
Jeffrey A LoebDepartment of Neurology and Rehabilitation, The University of Illinois at Chicago, NPI North Bldg., Room 174N, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA.
John RavitsALS and Neuromuscular Translational Research University of California, San Diego, CA, 92093, USA. jravits@health.ucsd.edu.ORCID http://orcid.org/0000-0001-6521-4649
Fei SongDepartment of Neurology and Rehabilitation, The University of Illinois at Chicago, NPI North Bldg., Room 174N, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA. feisong@uic.edu.ORCID https://orcid.org/0000-0002-1705-1686

Funding

UCSD Microscopy Core grant NINDS P30NS047101
6 · The paper itself

Abstract

The hallmark neuropathological feature of upper motor neuron (UMN) degeneration in amyotrophic lateral sclerosis (ALS) is the "sclerosis" of the lateral corticospinal tract (CST)-the major axonal pathway connecting UMNs to lower motor neurons (LMNs). However, few studies since Charcot's original descriptions in the nineteenth century have directly correlated clinical UMN phenotypes with corresponding neuropathological findings. We examined the pathology of the lateral CST at the cervical, thoracic, and lumbar levels of the spinal cord from ALS patients with predominantly UMN (UMN-p) phenotypes and compared it with that in patients with predominantly LMN (LMN-p) phenotypes. We assessed myelin loss, axonal degeneration, neuroinflammation, and TDP-43 pathology. Spinal cords from UMN-p ALS cases exhibited pronounced myelin loss in the lateral CST compared to LMN-p cases and controls, consistent with clinical phenotyping. Quantitative analysis revealed significant axonal loss across all axon diameter ranges in UMN-p ALS, which was more severe than in LMN-p ALS. Importantly, axonal loss was more pronounced in the lumbar than in the cervical spinal cord. We identified a distinct population of foamy, inflammatory microglia localized to regions of severe myelin and axonal loss in UMN-p ALS. TDP-43 was measurably increased in the UMN axons of the lateral and ventral CSTs. In summary, "lateral sclerosis" of ALS correlates to clinically imputed UMN degeneration. It consists of a combination of myelin loss, distal greater than proximal axonal degeneration, inflammatory microglial activation within the CSTs, and abnormally increased axonal TDP-43. The length-dependent gradient of motor axonal loss supports a "dying-back" process. A detailed comparison of "dying-forward" and "dying-forward" is provided in the Discussion. The association of loss of axons and myelin with abnormal microglial activity shows glio-axonal interactions in UMN axon degeneration, the latter CST (lateral sclerosis) across all three spinal cord levels in the ALS UMN-p samples but does not establish a causal relationship.

Indexed as

Amyotrophic Lateral SclerosisAxonsMotor NeuronsPyramidal TractsAdultAgedDNA-Binding ProteinsFemaleHumansMaleMiddle AgedMyelin SheathNerve DegenerationSpinal CordDNA-Binding ProteinsAmyotrophic lateral sclerosisAxon neurodegenerationCorticospinal tractsDying backMyelin lossNeuroinflammation

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.